Pfizer, IIT Delhi Launch Innovation & IP Program

The objective of 'The Pfizer IIT-Delhi Innovation and IP Program' is to nurture, support, celebrate and reward healthcare innovations that are made in India.

Pfizer Set To Buy Allergan For $150 Billion To Create World's Biggest Drug Maker

The deal is sure to draw political ire in a US presidential election year because Pfizer would redomicile to Ireland, where Allergan is registered, in a so-called 'inversion' that would slash its corporate tax rate

Regulators Battle Big Pharma Over Cough Syrup Abuse, Reducing Supplies

Pacific Trade Pact Faces Opposition In US Congress

Pfizer Sells Its Thane Plant To Vidhi Research

India Rejects Patent On Pfizer's Arthritis Drug

India Rejects Patent On Pfizer's Arthritis Drug

Pfizer To Close Down Its Thane Plant

India To Add More AIDS, TB Drugs To Essential List

Pfizer To Acquire Hospira For $15 Billion

Obama Tax Plan Targets Foreign Profits Of Firms

Pfizer, Ranbaxy Win Dismissal Of Lawsuit Over Generic Lipitor

How USIBC Lost Pfizer, Roche

Astrazeneca's Indian Unit Surges On Takeover Report

China Shares Down, Aussie Drops After Inflation Data